Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/02/20 → 31/12/25 |
Keywords
- Neurodegenerative diseases
- Alzheimer's disease
- Clinical trial
Clinical Trial Phase
- Phase II
- Phase III (a & b)
Open Label Extension Study for Patients with Early Alzheimer's Disease (AD) Enrolled in Study ANAVEX2-73-AD-004.
- O'Brien, Terence (Primary Chief Investigator (PCI))
- Burn, Katherine (Project Manager)
Project: Research